comparemela.com

Latest Breaking News On - Hilde hukkelberg - Page 1 : comparemela.com

Cytovation Strengthens its Board of Directors for Next Phase of Development

/PRNewswire/ Cytovation ASA, a clinical stage immune-oncology company focused on the development of CyPep-1, its first-in-class targeted tumor membrane.

Norway
Oslo
Ireland
United-kingdom
Switzerland
Haukeland
Hordaland
Norwegian
Hilde-hukkelberg
Kongstun-arnesen
Federico-grego
Livh-dyrnes

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.